A tradition of innovation
EDAP TMS: History and Innovations in treatment of prostate cancer and urinary tract stones
Since it was founded in 1979, EDAP TMS has been committed to introducing new and innovative technologies for a minimally-invasive approach to treating urological disorders. These proprietary technologies such as Focused Ultrasound or Piezo-electric shock waves have yielded new minimally invasive procedures for the treatment of several pathologies such as benign prostatic hyperplasia, localized prostate cancer or urinary tract stones. EDAP TMS' design philosophy is to develop minimally-invasive devices for the benefit of the patient associating treatment efficacy and safety. The strength of EDAP TMS Research and Development activity is to master mechanical, acoustic, electronic and IT technologies to produce state-of-the-art and ergonomic medical devices.
History & Innovations
EDAP TMS products are alternatives to traditional surgical procedures which often involve high costs, significant side effects and long recovery times. Founded in 1979, the Company EDAP originally specialized in the manufacturing and distribution of ultrasound scanners and produced the first piezo-electric lithotripter in 1985. Following a merger with Technomed International S.A. in 1994, EDAP TMS launched various generations of lithotripters, urological laser and Prostate Hyperplasia treatment devices (Prostatron) using TUMT (TransUrethral Microwave Therapy) while developing HIFU technology to treat Prostate Cancer. Today, the core business of EDAP TMS is backed by a solid portfolio of patents and innovations in both ESWL and HIFU technologies.
HIFU innovations and patents
2013 - Focal One
is launched upon CE mark approval. It combines elastic fusion with MRI together with a new Dynamic Focusing HIFU probe and Contrast-Enhanced Ultrasound in order to provide the optimal tool for focal therapy of Prostate Cancer.
2005 - Ablatherm HIFU Integrated Imaging
HIFU Integrated Imaging is launched. The probe integrates both imaging and treatment transducers.
2000 - Ablapak
Disposable kit patent.
1999-2000 - CE Mark
Ablatherm® HIFU receives the CE mark and industrial production starts.
1999 - Ablasonic
Patent covering Ablasonic® cooling and ultrasound-wave transmitting fluid.
1996 - Ablatherm Multicenter clinical trial
The first multicenter study on Ablatherm® HIFU is launched.
1994 - Patient protection
Patent covering rectal wall monitoring function.
1993 - First prostate cancer treatment
Ablatherm® HIFU is used for the first prostate cancer treatment on men (prototype device).
1991 - Ablatherm
Patent on Ablatherm®
transducer design covering geometry and materials.
1989 - HIFU technology
ESWL innovations and patents
2010 - Visio-Track
Introduced with the launch of the Sonolith®
i-move, the Visio-Track system allows a freeline ultrasound localization and tracking for a reduced radiation dose during ESWL treatments.
2007 - Stone Locking System
Introduced with the launch of Sonolith®
i-sys, the Stone Locking system allows the automatic positioning of the shockwave source on the target based on the X-Ray or Ultrasound image.
1994 - Electroconductive Technology
EDAP TMS and INSERM jointly develop the patented Electroconductive technology for Sonolith®
1990 - Hydrophone
Sonolith® hydrophone patent covering pressure regulation technology on ESWL shock-wave generators.
1986 - Ultrasound Imaging Arm
First ultrasound imaging navigator for ESWL (ultrasound imaging arm) on the Sonolith® 2000.
1985 - Sonolith 2000
Cooperation between EDAP TMS and the INSERM (French Institute of Medical Research) leading to the development of the Sonolith®
2000 equipped with a conventional electrohydraulic generator.
1984 - Sonolith LT01
Piezo-electric lithotripsy with in-line sonography (LT01).